Hemply Balance (HMPLY) Q2 2025 earnings summary

Executive summary

• Revenue for Q2 2025 was 81 TSEK, down 88.5% year-over-year, mainly due to missing orders from the Japanese distributor.

• Net loss for Q2 2025 was -196 TSEK, compared to a profit of 280 TSEK in Q2 2024.

• The company is prioritizing a structural transaction, such as a reverse acquisition, in 2025.

• No significant events occurred during the quarter; post-quarter, negotiations with Dendrio Solutions SRL ended.

Financial highlights

• Q2 2025 gross margin was 62.8%, down from 89.7% in Q2 2024.

• EBITDA for Q2 2025 was -195 TSEK, compared to 280 TSEK in Q2 2024.

• H1 2025 revenue was 330 TSEK, a 65.1% decrease year-over-year.

• Cash flow from operations in Q2 2025 was -100 TSEK, compared to -296 TSEK in Q2 2024.

• Equity as of June 30, 2025, was 876 TSEK, down from 1,464 TSEK a year earlier.

Outlook and guidance

• Discussions are ongoing for new orders in Q3 2025 with the Japanese distributor.

• The board's top priority remains executing a structural transaction, such as a reverse acquisition, within 2025.